| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.4 |